Literature DB >> 24752184

Rheumatoid arthritis: Is imaging needed to define remission in rheumatoid arthritis?

Mikkel Østergaard1, Signe Møller-Bisgaard2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24752184     DOI： 10.1038/nrrheum.2014.63

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  10 in total

1.  Ultrasonographic evaluation of joint involvement in early rheumatoid arthritis in clinical remission: power Doppler signal predicts short-term relapse.

Authors:  Carlo A Scirè; Carlomaurizio Montecucco; Veronica Codullo; Oscar Epis; Monica Todoerti; Roberto Caporali
Journal:  Rheumatology (Oxford)       Date:  2009-06-26       Impact factor: 7.580

2.  Patients with RA in remission on TNF blockers: when and in whom can TNF blocker therapy be stopped?

Authors:  Benazir Saleem; Helen Keen; Vincent Goeb; Rekha Parmar; Sharmin Nizam; Elizabeth M A Hensor; Sarah M Churchman; Mark Quinn; Richard Wakefield; Philip G Conaghan; Frederique Ponchel; Paul Emery
Journal:  Ann Rheum Dis       Date:  2010-04-26       Impact factor: 19.103

Review 3.  Should modern imaging be part of remission criteria in rheumatoid arthritis?

Authors:  Espen A Haavardsholm; Elisabeth Lie; Siri Lillegraven
Journal:  Best Pract Res Clin Rheumatol       Date:  2012-12       Impact factor: 4.098

4.  Whole-body MRI assessment of disease activity and structural damage in rheumatoid arthritis: first step towards an MRI joint count.

Authors:  Mette Bjørndal Axelsen; Iris Eshed; Anne Duer-Jensen; Jakob M Møller; Susanne Juhl Pedersen; Mikkel Østergaard
Journal:  Rheumatology (Oxford)       Date:  2014-01-03       Impact factor: 7.580

5.  Power Doppler ultrasound, but not low-field magnetic resonance imaging, predicts relapse and radiographic disease progression in rheumatoid arthritis patients with low levels of disease activity.

Authors:  Violaine Foltz; Frédérique Gandjbakhch; Fabien Etchepare; Carole Rosenberg; Marie Laure Tanguy; Sylvie Rozenberg; Pierre Bourgeois; Bruno Fautrel
Journal:  Arthritis Rheum       Date:  2012-01

6.  Presence of significant synovitis in rheumatoid arthritis patients with disease-modifying antirheumatic drug-induced clinical remission: evidence from an imaging study may explain structural progression.

Authors:  A K Brown; M A Quinn; Z Karim; P G Conaghan; C G Peterfy; E Hensor; R J Wakefield; P J O'Connor; P Emery
Journal:  Arthritis Rheum       Date:  2006-12

7.  EULAR recommendations for the use of imaging of the joints in the clinical management of rheumatoid arthritis.

Authors:  Alexandra N Colebatch; Christopher John Edwards; Mikkel Østergaard; Désirée van der Heijde; Peter V Balint; Maria-Antonietta D'Agostino; Kristina Forslind; Walter Grassi; Espen A Haavardsholm; Glenn Haugeberg; Anne-Grethe Jurik; Robert B M Landewé; Esperanza Naredo; Philip J O'Connor; Ben Ostendorf; Kristina Potocki; Wolfgang A Schmidt; Josef S Smolen; Sekib Sokolovic; Iain Watt; Philip G Conaghan
Journal:  Ann Rheum Dis       Date:  2013-03-21       Impact factor: 19.103

8.  Prediction of relapse after discontinuation of biologic agents by ultrasonographic assessment in patients with rheumatoid arthritis in clinical remission: high predictive values of total gray-scale and power Doppler scores that represent residual synovial inflammation before discontinuation.

Authors:  Taro Iwamoto; Kei Ikeda; Junichi Hosokawa; Mieko Yamagata; Shigeru Tanaka; Ayako Norimoto; Yoshie Sanayama; Daiki Nakagomi; Kentaro Takahashi; Koichi Hirose; Takao Sugiyama; Makoto Sueishi; Hiroshi Nakajima
Journal:  Arthritis Care Res (Hoboken)       Date:  2014-10       Impact factor: 4.794

9.  Determining a magnetic resonance imaging inflammatory activity acceptable state without subsequent radiographic progression in rheumatoid arthritis: results from a followup MRI study of 254 patients in clinical remission or low disease activity.

Authors:  Frédérique Gandjbakhch; Espen A Haavardsholm; Philip G Conaghan; Bo Ejbjerg; Violaine Foltz; Andrew K Brown; Uffe Møller Døhn; Marissa Lassere; Jane E Freeston; Inge Christoffer Olsen; Pernille Bøyesen; Paul Bird; Bruno Fautrel; Merete Lund Hetland; Paul Emery; Pierre Bourgeois; Kim Hørslev-Petersen; Tore K Kvien; Fiona M McQueen; Mikkel Østergaard
Journal:  J Rheumatol       Date:  2013-12-15       Impact factor: 4.666

10.  An explanation for the apparent dissociation between clinical remission and continued structural deterioration in rheumatoid arthritis.

Authors:  A K Brown; P G Conaghan; Z Karim; M A Quinn; K Ikeda; C G Peterfy; E Hensor; R J Wakefield; P J O'Connor; P Emery
Journal:  Arthritis Rheum       Date:  2008-10
  10 in total
  5 in total

1.  Risk factors of flare in rheumatoid arthritis patients with both clinical and ultrasonographic remission: a retrospective study from China.

Authors:  Jingjing Han; Yan Geng; Xuerong Deng; Zhuoli Zhang
Journal:  Clin Rheumatol       Date:  2017-06-22       Impact factor: 2.980

2.  Ultrasound in management of rheumatoid arthritis: ARCTIC randomised controlled strategy trial.

Authors:  Espen A Haavardsholm; Anna-Birgitte Aga; Inge Christoffer Olsen; Siri Lillegraven; Hilde B Hammer; Till Uhlig; Hallvard Fremstad; Tor Magne Madland; Åse Stavland Lexberg; Hilde Haukeland; Erik Rødevand; Christian Høili; Hilde Stray; Anne Noraas; Inger Johanne Widding Hansen; Gunnstein Bakland; Lena Bugge Nordberg; Désirée van der Heijde; Tore K Kvien
Journal:  BMJ       Date:  2016-08-16

3.  The Utility and Limitations of CRP, ESR and DAS28-CRP in Appraising Disease Activity in Rheumatoid Arthritis.

Authors:  Carl K Orr; Aurelie Najm; Francis Young; Trudy McGarry; Monika Biniecka; Ursula Fearon; Douglas J Veale
Journal:  Front Med (Lausanne)       Date:  2018-08-03

Review 4.  Structural integrity versus radiographic progression in rheumatoid arthritis.

Authors:  Ennio Giulio Favalli; Andrea Becciolini; Martina Biggioggero
Journal:  RMD Open       Date:  2015-08-15

5.  Can baseline ultrasound results help to predict failure to achieve DAS28 remission after 1 year of tight control treatment in early RA patients?

Authors:  D F Ten Cate; J W G Jacobs; W A A Swen; J M W Hazes; M H de Jager; N M Basoski; C J Haagsma; J J Luime; A H Gerards
Journal:  Arthritis Res Ther       Date:  2018-01-30       Impact factor: 5.156
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.